Centessa Pharmaceuticals gets FDA orphan drug status for SerpinPC in hemophilia B

Centessa Pharmaceuticals has secured orphan drug designation from the US Food and Drug Administration (FDA) for SerpinPC in hemophilia B treatment. According to the UK-based ... Read More